Gujarat Terce Laboratories Ltd
Mon 7/09/2026,12:23:0 | BSE : GUJTERC
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 41.75
Previous Close
₹ 40.69
Volume
69
Mkt Cap ( ₹ Cr)
₹ 30.42
High
₹ 41.75
Low
₹ 39.00
52 Week High
₹ 59.78
52 Week Low
₹ 29.00
Book Value Per Share
₹ 12.37
Dividend Yield
₹ 0.00
Face Value
₹₹10.00
What's Your Call?
Collective community sentiment on Gujarat Terce Laboratories Ltd
Your Vote -
Buy
28.57%
Hold
0.00%
Sell
71.43%
28.57%
14 users have voted
Option Chain
Analyzes market sentiment, predicts Gujarat Terce Laboratories Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Guj. Terce Lab. posts Q1 net loss of Rs 0.18 cr
-
Guj. Terce Lab. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Guj. Terce Lab. - Shareholder Meeting / Postal Ballot-Outcome of AGM
-
Guj. Terce Lab. - Announcement under Regulation 30 (LODR)-Change in Directorate
-
Guj. Terce Lab. - Announcement under Regulation 30 (LODR)-Change in Directorate
-
Guj. Terce Lab. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Guj. Terce Lab. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Guj. Terce Lab. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Guj. Terce Lab. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Guj. Terce Lab. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Guj. Terce Lab. - Board Meeting Outcome for Outcome Of The Board Meeting Held On 7 August 2026
-
Guj. Terce Lab. - Unaudited Standalone Financial Results Of The Company For The First Quarter Ended 30 June 2026
-
Guj. Terce Lab. - Board Meeting Intimation for Approving The Unaudited Standalone Financial Results Of The Company For The Fi
-
Guj. Terce Lab. - 41St AGM Of The Shareholders Of Gujarat Terce Laboratories Limited Will Be Held On 21St August, 2026 At 12:
-
Guj. Terce Lab. - Reg. 34 (1) Annual Report.
-
Guj. Terce Lab. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Guj. Terce Lab. has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026
Key fundamentals
Evaluate the intrinsic value of Gujarat Terce Laboratories Ltd stockÂ
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 11.0243 | 7.4193 | 10.9726 | 14.1349 | 15.2061 |
| Liabilities | 11.0243 | 7.4193 | 10.9726 | 14.1349 | 15.2061 |
| Equity | 7.7913 | 7.4203 | 7.4203 | 7.4203 | 7.4203 |
| Gross Profit | 3.748 | 3.8826 | 1.2668 | -2.1625 | 1.1174 |
| Net Profit | 2.2017 | -0.9787 | 0.2434 | -1.6716 | 0.8723 |
| Cash From Operating Activities | 1.7147 | 3.0591 | 2.5997 | 0.0267 | -0.4433 |
| NPM(%) | 4.63 | -1.94 | 0.5 | -3.57 | 2.17 |
| Revenue | 47.4727 | 50.1952 | 47.9747 | 46.7825 | 40.1337 |
| Expenses | 43.7247 | 46.3126 | 46.7079 | 48.945 | 39.0163 |
| ROE(%) | 23.98 | -10.66 | 2.65 | -18.21 | 9.5 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Gujarat Terce Laboratories Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 862.45 | 0.48 | 21.81 | 23.22 | -26.19 | 0.58 |
| Lotus Eye Hospital and Institute Ltd | 109.65 | 2.14 | 1562.14 | 84.62 | 0.39 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 15.34 | 0.00 | 0.00 | 175.70 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 551.75 | -0.65 | 0.00 | 90.67 | -363.14 | 0.00 |
Company Info
The conception of Gujarat Terce Laboratories Limited (GTLL) took place on 28th March, 1985. The establishment of an extensive Manufacturing Plant took place in the year 1992. Our assertive marketing and continual introduction of diverse products have contributed to our perpetual progress. 2019 -Gujarat Terce Laboratories acquires 50% stake in Terce Wellness LLP -Company has successfully incorporated Terce Wellness LLP, Associate Company as per section 2(6) of the companies Act, 2013. - Gujarat Terce Lab launches Vitol Mom Tablet. 2020-The Company is pleased to announce the launch of its New Territory at Patna, Bihar
The conception of Gujarat Terce Laboratories Limited (GTLL) took place on 28th March, 1985. The establishment of an extensive Manufacturing Plant took place in the year 1992. Our assertive marketing and continual introduction of diverse products have contributed to our perpetual progress. 2019 -Gujarat Terce Laboratories acquires 50% stake in Terce Wellness LLP -Company has successfully incorporated Terce Wellness LLP, Associate Company as per section 2(6) of the companies Act, 2013. - Gujarat Terce Lab launches Vitol Mom Tablet. 2020-The Company is pleased to announce the launch of its New Territory at Patna, Bihar
Read More
Parent Organisation
Gujarat Terce Laboratories Ltd.
Founded
28/03/1985
Managing Director
Mr.Aalap Prajapati
NSE Symbol
FAQ
The current price of Gujarat Terce Laboratories Ltd is
The 52-week high for Gujarat Terce Laboratories Ltd is
The market capitalization of Gujarat Terce Laboratories Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Gujarat Terce Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Gujarat Terce Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Gujarat Terce Laboratories Ltd shares.
The CEO of Gujarat Terce Laboratories Ltd is Mr.Aalap Prajapati, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
